Lazarski; Kiel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lazarski; Kiel.The latest application filed is for "macrocyclic fluorine substituted indole derivatives".
- Lazarski; Kiel - Cambridge MA
- Lazarski; Kiel - Boston MA
- Lazarski; Kiel - Watertown MA
| Patent | Date |
|---|---|
| Macrocyclic chlorine substituted indole derivatives Grant 11,447,504 - Thede , et al. September 20, 2 | 2022-09-20 |
| Substituted macrocyclic indole derivatives Grant 11,440,923 - Thede , et al. September 13, 2 | 2022-09-13 |
| Macrocyclic Fluorine Substituted Indole Derivatives App 20220281891 - Ferrara; Steven J. ; et al. | 2022-09-08 |
| Degraders And Degrons For Targeted Protein Degradation App 20220251061 - Phillips; Andrew J. ; et al. | 2022-08-11 |
| Macrocyclic indole derivatives Grant 11,401,278 - Furst , et al. August 2, 2 | 2022-08-02 |
| Macrocyclic fluorine substituted indole derivatives Grant 11,286,263 - Ferrara , et al. March 29, 2 | 2022-03-29 |
| Spirocyclic degronimers for target protein degradation Grant 11,185,592 - Phillips , et al. November 30, 2 | 2021-11-30 |
| Macrocyclic Indole Derivatives App 20210292341 - Furst; Laura ; et al. | 2021-09-23 |
| Macrocyclic Chlorine Substituted Indole Derivatives App 20210277022 - Thede; Kai ; et al. | 2021-09-09 |
| Substituted Macrocyclic Indole Derivatives App 20210269456 - Thede; Kai ; et al. | 2021-09-02 |
| Aryl Annulated Macrocyclic Indole Derivatives App 20210253598 - Thede; Kai ; et al. | 2021-08-19 |
| Macrocyclic indole derivatives Grant 10,981,932 - Johannes , et al. April 20, 2 | 2021-04-20 |
| Spirocyclic Degronimers For Target Protein Degradation App 20210106688 - Phillips; Andrew J. ; et al. | 2021-04-15 |
| Macrocyclic Fluorine Substituted Indole Derivatives App 20210079018 - Ferrara; Steven J. ; et al. | 2021-03-18 |
| Compounds App 20210079005 - Duplessis; Martin ; et al. | 2021-03-18 |
| 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide Compounds App 20210070739 - Duplessis; Martin ; et al. | 2021-03-11 |
| 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds Grant 10,882,848 - Duplessis , et al. January 5, 2 | 2021-01-05 |
| C3-carbon linked glutarimide degronimers for target protein degradation Grant 10,849,982 - Phillips , et al. December 1, 2 | 2020-12-01 |
| Bifunctional Molecules That Degrade Egfr App 20200361930 - Duplessis; Martin ; et al. | 2020-11-19 |
| Bifunctional Inhibitors With Egfr Having A E3 Ubiquitin Ligase Moiety App 20200308171 - Jaeschke; Georg ; et al. | 2020-10-01 |
| Spirocyclic degronimers for target protein degradation Grant 10,660,968 - Phillips , et al. | 2020-05-26 |
| Macrocyclic Indole Derivatives App 20200087322 - Johannes; Sarah Anna Liesa ; et al. | 2020-03-19 |
| 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide Compounds App 20190308955 - Duplessis; Martin ; et al. | 2019-10-10 |
| Amine-linked C3-glutarimide Degronimers For Target Protein Degradation App 20190076539 - Phillips; Andrew J. ; et al. | 2019-03-14 |
| Spirocyclic Degronimers For Target Protein Degradation App 20190076540 - Phillips; Andrew J. ; et al. | 2019-03-14 |
| C3-carbon Linked Glutarimide Degronimers For Target Protein Degradation App 20190076542 - Phillips; Andrew J. ; et al. | 2019-03-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 